Catalyst Wire Dossier Catalyst Wire Dossier

Aza-Ven

azacitidine-venetuzumab? (unclear from title; provide best guess if known)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Aza-Ven, covering 2021-06-01 to 2021-06-01. Get the full timeline:

Most recent: Clinical Trial Update: Aza-Ven Followed by Reduced Toxicity Conditioning Regimen (MBF) as Salvage Therapy for Refractory AML. [Phase 2]

See pricing